Validation study for prognostic scoring system for perihilar cholangiocarcinoma surgery using preoperative factors

Langenbecks Arch Surg. 2023 Nov 8;408(1):430. doi: 10.1007/s00423-023-03145-3.

Abstract

Purpose: Recently, systemic inflammatory responses (SIR) have been shown to play a pivotal role in the development and progression of cancer. We previously reported that four factors, serum carcinoembryonic antigen (> 7 ng/dL), serum albumin (< 3.5 g/dL), C-reactive protein (> 0.5 mg/dL), and platelet-lymphocyte ratio (PLR; > 150), were independent prognostic factors after perihilar cholangiocarcinoma (PHCC) surgery. We also advocated a prognosis predictive preoperative prognostic score (PPS) using these four factors and showed that PPS could predict patients' prognosis on survival. This retrospective study sought to validate preoperatively available prognostic factors for survival after major hepatectomy as reported previously, including PPS for PHCC.

Methods: We retrospectively validated our PPS score and reported SIR scoring systems using the data of 125 consecutive patients who underwent PHCC surgery from January 2010 to November 2020.

Results: PPS was an independent preoperative prognostic factors for survival. The T and N categories were independent prognostic factors. Other SIR scores were not independent preoperative factors in the univariate analysis. Among SIR scores, only the PPS was found to be associated with OS and disease-free survival. The PPS was also associated with histopathological factors (T and N categories).

Conclusion: PPS could be useful in predicting long-term survival after PHCC and may be a more useful scoring system than other SIR systems.

Keywords: Perihilar cholangiocarcinoma; Platelet-lymphocyte ratio; Prognostic predicting score; Systematic inflammatory response.

MeSH terms

  • Bile Duct Neoplasms* / surgery
  • C-Reactive Protein
  • Humans
  • Klatskin Tumor* / surgery
  • Prognosis
  • Retrospective Studies

Substances

  • C-Reactive Protein